COVID-19: Vaccine | Testing | Self-assessment | Patient & Visitor Safety | Visitor Policy
Home > Clinical Trials > Clinical Trial Details
Back to Results
Request Additional Trial InformationFull Trial Details: ClinicalTrials.gov
Condition: Coronary Artery DiseaseStudy Type: InterventionalPhase: Phase IIIStudy Start Date: 05/05/2015Study Completion Date: TBD
This study is intended to demonstrate that the Combo stent platform shows superiority to an imputed BMS performance goal, noninferior effectiveness and safety vs best-in-class second-generation everolimus-eluting stent, and evidence of mechanistic activity of the anti-CD34-Ab EPC capture technology with healthy level of intimal tissue coverage superior to that of the best-in-class EES.
Find an Adventist HealthCare affiliated doctor by calling our FREE physician referral service at 800-642-0101 or by searching our online physician directory.
Set Your Location
Setting your location helps us to show you nearby providers and locations based on your healthcare needs.